Abbott LaboratoriesvsCardinal Health

ABT and CAH stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$106.17

Value $184B

-1.19%
ABT's page

CAH

Cardinal Health, Inc.

$283.16

Value $65.9B

-0.24%
CAH's page

Abbott Laboratories (ABT) has a market value of $184B and Cardinal Health (CAH) $65.9B. Over the last year, with dividends, ABT moved -16.7% and CAH +39.2%. The P/E is 39.3 for ABT and 36.2 for CAH. Dividend yield: ABT 2.37%, CAH 0.73%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$184B

    CAH$65.9B

    ABT is 2.8 times CAH

  • Revenue, 12 months

    ABT$48.2B

    CAH$258B

    CAH is 5.3 times ABT

  • Net income, 12 months

    ABT$4.7B

    CAH$1.8B

    ABT is 2.6 times CAH

  • Operating margin

    ABT13.8%

    CAH1.1%

    12.7 points apart

  • ROIC

    ABT6.3%

    CAH35.7%

    29.4 points apart

  • P/E

    ABT39.3

    CAH36.2

    ABT is 1.1 times CAH

  • Dividend yield

    ABT2.4%

    CAH0.7%

    1.7 points apart

  • 5-year return

    ABT-10.4%

    CAH+526.5%

    536.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-10.4%

CAH+526.5%

20040060020222023202420252026
Returns by period
PeriodABTWith dividendsCAHWith dividends
1 year since November 14, 2025-16.7%Price -18.7%+39.2%Price +37.9%
3 years since November 17, 2023+13.6%+4.3% a yearPrice +6.7%+185.8%+41.9% a yearPrice +173.9%
5 years since November 16, 2021-10.4%-2.2% a yearPrice -18.9%+526.5%+44.3% a yearPrice +465.9%
10 years since November 17, 2016+217.2%+12.2% a yearPrice +162.9%+420.2%+17.9% a yearPrice +295.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesCAHCardinal Health

Valuation

ABTCAH
Valuation
Price$106.17$283.16
Market value$184B$65.9B
Enterprise value (EV)$211B$69.4B
P/E39.336.2
P/E, 5-year median33.730.7
P/B3.6–
EV/EBIT31.825.7
Free cash flow yield3.7%7.4%

Results and growth

ABTCAH
Results and growth
Revenue, 12 months$48.2B$258B
Net income, 12 months$4.7B$1.8B
Free cash flow, 12 months$6.8B$4.9B
Earnings per share, 12 months$2.69$7.82
Revenue growth, year on year5.7%14.2%
Revenue growth a year, past+5.1%over 5 years+9.4%over 5 years
EPS growth a year, past+8.3%over 5 years+28.3%over 5 years

Margins and returns on capital

ABTCAH
Margins and returns on capital
Gross margin56.9%3.9%
Operating margin13.8%1.1%
Net margin9.8%0.7%
ROIC6.3%35.7%
ROE9.1%–

Balance sheet

ABTCAH
Balance sheet
Cash$4.3B$5.3B
Total debt$31.2B$8.8B
Net debt / EBITDA3.31.0
Interest cover6.7×7.9×

Dividends and buybacks

ABTCAH
Dividends and buybacks
Dividend yield2.4%0.7%
Dividend per share, 12 months$2.52$2.05
Dividend growth a year, past+10.4%over 5 years+1.0%over 5 years
Buyback yield0.5%2.1%
Shareholder yield2.9%2.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or CAH

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or Cardinal Health?

By market value, Abbott Laboratories ($184B) is about 2.8 times Cardinal Health ($65.9B), at today's prices.

How did ABT and CAH stock do over the last 10 years?

Since November 17, 2016, ABT's price moved +162.9% and CAH's +295.3%. With dividends: ABT +217.2% (+12.2% a year), CAH +420.2% (+17.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or CAH?

The dividend yield at today's price is 2.37% for Abbott Laboratories and 0.73% for Cardinal Health. Over the last twelve months they paid $2.52 and $2.05 per share.

What is the P/E of ABT and CAH?

At today's price, the P/E is 39.3 for ABT and 36.2 for CAH. The median of the last five years was 33.7 and 30.7, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or Cardinal Health?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 0.7% for Cardinal Health, and the operating margin 13.8% and 1.1%. Revenue was $48.2B and $258B.

Which is the better investment, Abbott Laboratories or Cardinal Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.